Categories: News

Sg Buloh Hospital COVID-19 patient first in SEA to be given trial drug Remdesivir

A COVID-19 patient currently undergoing treatment at Sungai Buloh Hospital will be the first patient in Southeast Asia to be administered the antiviral drug Remdesivir. The patient is the first of a hundred to be recruited for clinical trials from hospitals nationwide under the World Health Organisation (WHO).

Remdesivir is developed by American biotechnology company Gilead Sciences Inc. According to the company, the drug has been tested on animals against viral pathogens that are structurally similar to COVID-19, like MERS and SARS, which are also triggered by coronaviruses.

Remdesivir works by blocking the coronavirus’s RNA polymerase—a key enzyme that this virus needs to replicate its genetic material in our bodies. However, the drug is still being tested against the SAR-CoV-2 (COVID-19) virus in clinical trials launched in the United States.

“We have received the drug and distributed it to nine hospitals. We have also recruited one case for the clinical trial, and we aim at getting 100 patients,” said Director-General of Health Datuk Dr Noor Hisham Abdullah.

While Remdesivir is still an experimental drug, Gilead Sciences said that it has improved COVID-19 patients’ outcomes, and said that their data suggests that Remdesivir works better when given earlier in the course of infection.

However, Dr Noor Hisham said it will probably take six months before the trial could be completed and the results would submitted to the WHO. They will then look into all the reports from clinical trials done around the world, including Malaysia, and study them according to their protocols.

There are currently (8th May) a total number of 6,535 COVID-19 cases in Malaysia, with a current death toll of 107 and a total of 4,864 recovered patients.

[ SOURCE, 2, IMAGE SOURCE ]

Recent Posts

Every Transaction Could Make You a Monthly Millionaire – Here’s How with Maybank’s MAE

This post is brought to you by Maybank. Unlock more than just transactions with MAE’s…

11 hours ago

Oppo Find X8 series: Launching in Malaysia on 30th November 2024, priced from RM3,699

After making its debut in China late last month, the Oppo Find X8 series has…

15 hours ago

Hyundai Ioniq 9: The brand’s first 3-row electric SUV, offers up to 429hp and 620km of range

Hyundai has officially unveiled the new Ioniq 9 which marked yet another expansion to its…

16 hours ago

BMW Group leads Malaysia’s premium EV segment, long term certainty needed for local assembly

BMW Group remains bullish in its commitment to drive sustainable mobility across the Southeast Asian…

23 hours ago

Dongfeng Box Malaysia: First public test drive event is happening on 23 to 24 Nov

After completing its 45,000km road test in Malaysia earlier this year, Dongfeng Box will finally…

1 day ago

Take control of your health: Meet the medically certified HUAWEI WATCH D2 with Ambulatory Blood Pressure Monitoring

This post is brought to you by HUAWEI. Hypertension is a significant global health concern,…

2 days ago

This website uses cookies.